GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
FOSBENNER, DAVID T.,GRAYBILL, TODD L.,KANG, JIANXING,KING, BRYAN W.,LAN, YUNFENG,LEISTER, LARA KATHRYN,MAHAJAN, MUKESH K.,MEHLMANN, JOHN F.,MORALES-RAMOS, ANGEL I.,PESIRIDIS, GEORGE SCOTT,RAMANJULU, J
申请号:
CA3077337
公开号:
CA3077337A1
申请日:
2018.10.04
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Disclosed are compounds having the formula: (I) wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, R17, Rx, and Ry are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.